Table 2 Summary of FDR-significant (FDR < 0.1) cis-pQTLs identified in DAISY

From: Genetic mapping of complement system proteins for islet autoimmunity in children with high risk of T1D

   

SRM no. significant cis-pQTLs

Exsera no. significant cis-pQTLs

Pathway(s)

Protein

Chr

Pooled

Case-stratified

Total

Pooled

Case-stratified

Total

Lectin

MBL2

10

0

0

0

14

4

14

Classical

C1QC

1

0

0

0

3

2

5

C1R

12

0

0

0

--

--

--

C1S

12

0

0

0

--

--

--

Classical and Lectin

C2

6

0

0

0

0

5

5

C4

6

--

--

--

0

0

0

C4A

6

17

0

17

--

--

--

C4B

6

9

0

9

0

1

1

Alternative

CFB

6

26

0

26

0

0

0

CFD

19

--

--

--

0

0

0

CFP

X

0

0

0

0

0

0

Terminal

C5

9

0

0

0

0

0

0

C5A

9

--

--

--

5

3

5

Terminal (MAC)

C5B

9

--

--

--

0

3

3

C6

5

3

0

3

--

--

--

C7

5

0

0

0

--

--

--

C8A

1

29

0

29

--

--

--

C8B

1

2

0

2

--

--

--

C8G

9

0

0

0

--

--

--

C9

5

0

0

0

--

--

--

Alternative and terminal

C3

19

0

0

0

0

0

0

C3A

19

--

--

--

0

0

0

C3B

19

--

--

--

0

1

1

CFH

1

50

0

50

69

0

69

CFI

4

0

0

0

0

3

3

  1. DAISY Diabetes Autoimmunity Study in the Young study, MAC membrane attack complex; 10 overlapped proteins between SRM and Exsera are highlighted in bold, SRM selected reaction monitoring mass spectrometry assay, FDR false discovery rate, Total union of significant cis-pQTLs after fine mapping from pooled and case-stratified analyses, protein data was not available in the corresponding assay; the pathway classification of proteins is based on ref. 14.